{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:51:23Z","timestamp":1791413483354,"version":"4.3.3"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7866","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T22:09:57Z","timestamp":1492207797000},"page":"979-982","source":"Crossref","is-referenced-by-count":21,"title":["Alert Regarding Cisplatin-induced Severe Adverse Events in Cancer Patients with Xeroderma Pigmentosum"],"prefix":"10.2169","volume":"56","author":[{"given":"Makoto","family":"Sumiyoshi","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Soda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Sadanaga","sequence":"additional","affiliation":[{"name":"Department of Surgery, Saiseikai Fukuoka General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Maruta","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Dotsu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Ogawara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Menck CF, Munford V. DNA repair diseases: What do they tell us about cancer and aging? Genet Mol Biol 37: 220-233, 2014.","DOI":"10.1590\/S1415-47572014000200008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Alt A, Lammens K, Chiocchini C, et al. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta. Science 318: 967-970, 2007.","DOI":"10.1126\/science.1148242"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fadda E. Role of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assembly. Comput Struct Biotechnol J 14: 78-85, 2015.","DOI":"10.1016\/j.csbj.2015.11.007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rose MC, Kostyanovskaya E, Huang RS. Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer. Genomics Proteomics Bioinformatics 12: 198-209, 2014.","DOI":"10.1016\/j.gpb.2014.10.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Srivastava AK, Han C, Zhao R, et al. Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells. Proc Natl Acad Sci USA 112: 4411-4416, 2015.","DOI":"10.1073\/pnas.1421365112"},{"key":"6","unstructured":"6. Wu X, Fan W, Xu S, Zhou Y. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells. Clin Cancer Res 9: 5874-5879, 2003."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Albertella MR, Green CM, Lehmann AR, O'Connor MJ. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res 65: 9799-9806, 2005.","DOI":"10.1158\/0008-5472.CAN-05-1095"},{"key":"8","unstructured":"8. Moriwaki S, Kanda F, Hayashi M, Yamashita D, Sakai Y, Nishigori C. Clinical practice guideline on xeroderma pigmentosum. The Japanese Jounal of Dermatology 125: 2013-2022, 2015 (in Japanese)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gregory MT, Park GY, Johnstone TC, Lee YS, Yang W, Lippard SJ. Structural and mechanistic studies of polymerase \u03b7 bypass of phenanthriplatin DNA damage. Proc Natl Acad Sci USA 111: 9133-9138, 2014.","DOI":"10.1073\/pnas.1405739111"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Callejo A, Sed\u00f3-Cabez\u00f3n L, Dom\u00e8nech Juan I, Llorens J. Cisplatin-induced ototoxicity: effects, mechanisms and protection strategies. Toxics 3: 268-293, 2015.","DOI":"10.3390\/toxics3030268"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wozniak AJ, Crowley JJ, Blcerzak SP, et al. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 16: 2459-2465, 1998.","DOI":"10.1200\/JCO.1998.16.7.2459"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Le Chevalier T, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 12: 360-367, 1994.","DOI":"10.1200\/JCO.1994.12.2.360"},{"key":"13","unstructured":"13. Kraemer KH, DiGiovanna JJ. Xeroderma pigmentosum. GeneReviews (the online database on the National Center for Biothechnology Information), February 13, 2014 [Internet]. [cited 2016 July 17]. Available from URL: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1397\/"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/8\/56_56.7866\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T14:53:25Z","timestamp":1498402405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/8\/56_56.7866\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7866","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}